Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
In Amgen v. Apotex, the Federal Circuit held that under the Biologics Price Competition and Innovation Act (“BPCIA”), “an applicant must provide a reference product sponsor with 180 days’ post-licensure notice before...more